Novo Nordisk | Fremdkapital



Loan Capital Veränderung Datum
ANI Pharmaceuticals USD 614.92M 302M 2024-12
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.23B 2.29B 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 51.45B 156M 2024-09
Novo Nordisk DKK 51.45B 156M 2024-09
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Prestige Brands USD 996.05M 55.67M 2024-12
Sanofi 13.41B 1.62B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 5.22B 1.35B 2024-12



Novo Nordisk Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.